These choices are often based on personal experience rather than clinical evidence, making provider guidance important
Many such changes for protein therapeutics (from vials to prefilled syringes or prefilled syringes to pen devices, for example) are considered to enhance patient convenience and ease of use
This article explores the difference between these two powerhouse molecules, examining the efficacy data, safety profiles, and, most importantly, the clinical implications for patients seeking advanced, comprehensive metabolic health in 2025 and beyond
Aggregate data are available from the authors upon reasonable request
Transcript 00:00 Dr
Steinberg B, Shuler C, Wilson S